Hong Fang Song sold $2.8M of CG Oncology (CGON)

Executed Sep 3 2025, disclosed Sep 4 2025, 1 day later.

Value, as filed

$2.8M

99,800 sh across 2 lots

Executed

Sep 3 2025

the trade date, as filed

Disclosed

Sep 4 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

HS Hong Fang Song Director profile →

Hong Fang Song (Director) filed 2 Form 4 reports in the past 24 months (0 purchases, 2 sales), most often in CG Oncology, Inc. (CGON). The largest single filing was $19.6M of CGON (700,000 sh × $28.00, as filed), executed Dec 16 2024.

The name

CGON CG Oncology, Inc. CGON · Healthcare · 14 filings in 24 months ticker →

Healthcare · CG Oncology, Inc., a late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Hong Fang Song in CGON

CGONSALE CG Oncology, Inc. $19.6M
700,000 sh × $28.00
Exec Dec 16 2024
Filed Dec 17 2024 · 5:30 PM ET